PIN22 Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Persons Over 50 Years of Age With Underlying Chronic Medical Conditions in Finland
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1089
https://www.valueinhealthjournal.com/article/S1098-3015(12)02802-1/fulltext
Title :
PIN22 Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Persons Over 50 Years of Age With Underlying Chronic Medical Conditions in Finland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02802-1&doi=10.1016/j.jval.2012.08.1089
First page :
A388
Section Title :
Infection
Open access? :
No
Section Order :
591